| |
|
|
|
|
|
|
|||
|
Blood, 25 June 2009, Vol. 113, No. 26, pp. 6648-6657. Prepublished online as a Blood First Edition Paper on March 13, 2009; DOI 10.1182/blood-2008-09-181156.
Submitted September 29, 2008
Department of Medicine, Case Western Reserve University, Cleveland, OH, United States * Corresponding author; email: mary.laughlin{at}case.edu.
The reduced expression of NFAT1 protein in Umbilical Cord Blood (UCB)-derived CD4+ T-cells and the corresponding reduction in inflammatory cytokine secretion following stimulation in part underlies their phenotypic differences from adult blood (AB) CD4+ T-cells. This muted response may contribute to the lower incidence and severity of high-grade acute graft-versus-host disease (aGVHD) exhibited by UCB grafts. Here we provide evidence that a specific microRNA, miR-184, inhibits NFAT1 protein expression elicited by UCB CD4+ T-cells. Endogenous expression of miR-184 in UCB is 58.4-fold higher compared to AB CD4+ T-cells, and miR-184 blocks production of NFAT1 protein through its complementary target sequence on the NFATc2 mRNA without transcript degradation. Furthermore, its negative effects on NFAT1 protein and downstream IL-2 transcription are reversed through antisense blocking in UCB and can be replicated via exogenous transfection of precursor miR-184 into AB CD4+ T-cells. Our findings reveal a previously uncharacterized role for miR-184 in UCB CD4+ T-cells and a novel function for microRNA in the early adaptive immune response.
Related Article in Blood Online:
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2009 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||